Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario

Precision oncology has a prominent role in nonsquamous non-small cell lung cancer (nsNSCLC) treatment progress; however, its access in a real-world scenario might be limited. To investigate the time spent in nsNSCLC molecular profile evaluation and its influence on clinical decisions. nsNSCLC patien...

Full description

Saved in:
Bibliographic Details
Published in:Journal of market access & health policy 2022-12, Vol.10 (1), p.2077905-2077905
Main Authors: Duarte, Flavia A., Ferreira, Carlos Gil, Dienstmann, Rodrigo, Ferrari, Bruno L., Costa E Silva, Matheus, Nazareth A. Junior, Pedro, Guilherme de O. Salles, Paulo, Henrique C. Diniz, Paulo
Format: Article
Language:English
Subjects:
Biomarkers
drug access
Lung cancer
Medical treatment
non-small cell lung cancer
Patients
Practical Applications
Precision medicine
Time
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Precision oncology has a prominent role in nonsquamous non-small cell lung cancer (nsNSCLC) treatment progress; however, its access in a real-world scenario might be limited. To investigate the time spent in nsNSCLC molecular profile evaluation and its influence on clinical decisions. nsNSCLC patients who underwent molecular testing in a private referral Brazilian center between November 2015 and February 2020 were identified. The interval from nsNSCLC diagnosis to the characterization of the molecular profile was determined. Other outcomes, focusing on the biomarker tissue journey, were also assessed. In this cohort (n = 78), the median time between the advanced nsNSCLC diagnosis and biomarker characterization was 40.5 days (range, 29.5-68.5). The median interval between the diagnosis and the test request was longer than the interval between the request and the results (respectively 29.0 versus 12.0 days; p
ISSN:2001-6689
2001-6689
DOI:10.1080/20016689.2022.2077905